| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
The latest
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss infectious disease activity around the nation.
Today's Highlights Include: Minnesota's COVID-19 breakthrough cases point to vaccine effectiveness, Biden administration withdraws its vaccine-or-test mandate for businesses, and tips to help making a COVID-19 vaccine shot less scary for young children.
This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice and Dr. Pritt look beyond the borders of the United States and discuss the impact COVID-19 is having around the world.
As a regular contributor to Forbes regarding COVID-19, Dr. Matthew Binnicker offers expert health information to help people better understand the ever-changing nature of the pandemic.
Today's Topic Features: Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib.
Topic's Include: Mayo Clinic Minute: Looking ahead after 2 years of COVID-19 pandemic, cancer treatment may inhibit immune response to COVID-19 vaccination, and Mayo Clinic Q&A- why getting infected with COVID-19 is still a bad idea.
Today's Highlights Include: Study: E-cigarette users with COVID-19 more likely to experience symptoms, Omicron may peak next week in Minnesota, says Mayo data scientist, and Fauci says FDA could authorize Pfizer's Covid vaccine for kids under 5 in the next month.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice and Dr. Pritt talk about the increased availability of antigen tests for COVID-19 and review when it’s most appropriate to use an antigen test.
As omicron surges and demand for testing spikes, Dr. Morice was among a group of experts called on to discuss access to COVID-19 testing, as well as the ins-and-outs of different test options.
Joseph Yao, M.D., explains how Mayo Clinic Laboratories’ SARS four-target test for viral respiratory disease can enhance patient care. The test detects RNA from SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus, or RSV. RSV — which poses significant risks for infants and patients with underlying health conditions — can be treated if diagnosed early.
Today's Topic Features: Clinical, histological and molecular profiling of different stages of alcohol-related liver disease.
Topic's Include: Mayo Clinic’s statement on the declaration of local emergency requiring masking in indoor spaces in Rochester, how to decide what mask is best for you, and what is ‘flurona’ and why a Mayo Clinic expert says flu cases are rising.
Today's Highlights Include: Minnesota stops requiring child care providers to quarantine kids exposed to COVID-19, doctors discuss the future of COVID-19, and should you swab your throat with a rapid Covid test?